Abstract

Purpose:Head and neck cancer (HNC) patients experience various posttreatment side effects that decrease quality of life (QOL). Some previous study reported that QOL of HHC patients were returned baseline (before treatment) after a year post treatment. However, acute stage longitudinal changes of QOL in HNC patients remains unclear. This point might be important for early reintegration of HNC patients. This study aimed to investigate the acute stage longitudinal change of the relationship between QOL and oral function in HNC patients had surgery. Methods:45 HNC patients (23 men) scheduled for surgical treatment were enrolled in this study. Primary tumor sites were 22 tongue, 5 maxilla, 4 mandible, 3 pharynx and others. Weight, body mass index (BMI), whole body soft lean mass (SLM), and skeletal muscle mass (SMM) were evaluated as muscle mass-related measurements. Lip closure force (LC) and tongue pressure (TP) were evaluated as oral function measurements. Feeding function was evaluated using the Functional Oral Intake Scale (FOIS). QOL was assessed using the European Organization for Research and Treatment of Cancer QOL Questionnaire QLQ-C30 and H&N 35. Measures were evaluated at pre-surgical treatment (PT), and 1 month (1M) and 3 months (3M) after surgery. The change of QOL parameters and relationships between measurements were assessed.Results:For QOL assessments, role functioning, fatigue, speech problems, trouble with social eating, trouble with social contact, and opening mouth significantly decreased from PT to 1M, but significantly increased from 1M to 3M. Weight, BMI, SLM, SMM, LC, TP, and FOIS demonstrated significant relationships with QOL from PT to 1M. Meanwhile, from 1M to 3M, weight, BMI, SLM, SMM, LC, and FOIS showed significant relationships with QOL assessments.Conclusions:Both oral function and muscle mass-related measurements significantly affected QOL in HNC patients.

Highlights

  • Both the prevalence and survival rates of head and neck cancer (HNC) are increasing (Young et al, 2015) owing to advances in medical technology

  • A significant reduction was observed at 1 month (1M), while no significant increase was noted from 1M to 3 months (3M)

  • Patients underwent only surgical treatment, and oral function decreased after surgical treatment, it was recovered after 3 months

Read more

Summary

Introduction

Both the prevalence and survival rates of head and neck cancer (HNC) are increasing (Young et al, 2015) owing to advances in medical technology One of the most prevalent and debilitating side effects of HNC treatment is dysphagia (i.e., swallowing difficulty) (Ihara et al, 2018) that may develop as both acute and chronic complication of HNC treatment (Hutcheson et al.,2012; Van den Berg et al, 2014). Dysphagia has been reported in over 76% of HNC patients treated with concurrent chemotherapy (CRT). It decreases the patient’s quality of life (QOL) following HNC treatment (Kalyanam et al, 2018; Anuradha et al, 2013). QOL is considered to be an important factor in both treatment decision and outcome evaluation (Anuradha et al, 2013; Blazeby et al, 1995; Maciejewski et al, 2010; Gonçalves et al, 2012). QOL is necessary in multidirectional analysis and appropriate evaluation of treatment results

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call